Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)
TipRanksMay 3 10:11
Baird: Maintaining the LivaNova (LIVN.US) rating, adjusted from neutral to neutral, and adjusted the target price from $58.00 to $66.00.
Zhitong FinanceMay 2 18:50
Baird Maintains Neutral on LivaNova, Raises Price Target to $66
BenzingaMay 2 18:49
Needham: Reiterates the LivaNova (LIVN.US) rating and adjusted from buy to buy rating, target price is $72.00.
Zhitong FinanceMay 2 02:50
LivaNova Analyst Ratings
BenzingaMay 2 02:45
Needham Reiterates Buy on LivaNova, Maintains $72 Price Target
BenzingaMay 2 02:46
LivaNova: Strong Buy Rating Backed by Robust Growth and Positive Outlook
TipRanksMay 2 02:35
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), AnaptysBio (ANAB) and LivaNova (LIVN)
TipRanksApr 30 19:11
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
TipRanksApr 10 14:51
LivaNova Analyst Ratings
BenzingaMar 28 01:13
Analysts Have Conflicting Sentiments on These Healthcare Companies: LivaNova (LIVN), Vor Biopharma (VOR) and Neurogene (NGNE)
TipRanksMar 21 17:21
LivaNova Analyst Ratings
BenzingaMar 21 00:12
Needham Reiterates Buy on LivaNova, Maintains $72 Price Target
BenzingaMar 21 00:14
LivaNova's Aura6000 Poised for Success in OSA Market: A Buy Rating Overview
TipRanksMar 20 23:55
Barclays Maintains Equal-Weight on LivaNova, Raises Price Target to $61
BenzingaFeb 27 22:39
LivaNova Analyst Ratings
BenzingaFeb 27 22:38
Barclays Maintains Equal-Weight on LivaNova, Raises Price Target to $61
BenzingaFeb 26 20:23
LivaNova Analyst Ratings
BenzingaFeb 26 20:22
Baird Adjusts LivaNova's Price Target to $62 From $56, Keeps Neutral Rating
MT NewswiresFeb 23 00:47
LivaNova Analyst Ratings
BenzingaFeb 23 00:07
No Data
No Data